应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
BIVI BioVie Inc
休市中 05-24 16:00:00 EDT
0.4542
-0.0058
-1.26%
盘后
0.4700
+0.0158
+3.48%
19:49 EDT
最高
0.4690
最低
0.4402
成交量
85.80万
今开
0.4650
昨收
0.4600
日振幅
6.26%
总市值
2,769万
流通市值
1,684万
总股本
6,097万
成交额
38.73万
换手率
2.31%
流通股本
3,707万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Biovie Inc.盘中异动 股价大跌5.04%报0.462美元
自选股智能写手 · 04-22
Biovie Inc.盘中异动 股价大跌5.04%报0.462美元
Biovie Inc.盘中异动 股价大涨5.23%报0.521美元
自选股智能写手 · 04-12
Biovie Inc.盘中异动 股价大涨5.23%报0.521美元
Biovie Inc.盘中异动 股价大跌5.06%
自选股智能写手 · 04-03
Biovie Inc.盘中异动 股价大跌5.06%
Biovie Inc.盘中异动 早盘股价大跌5.00%
自选股智能写手 · 03-18
Biovie Inc.盘中异动 早盘股价大跌5.00%
Biovie Inc.盘中异动 早盘快速下跌5.42%
自选股智能写手 · 03-14
Biovie Inc.盘中异动 早盘快速下跌5.42%
Biovie Inc.盘中异动 急速下挫5.05%报0.857美元
自选股智能写手 · 03-07
Biovie Inc.盘中异动 急速下挫5.05%报0.857美元
Biovie Inc.盘中异动 早盘股价大涨147.98%报3.08美元
自选股智能写手 · 03-01
Biovie Inc.盘中异动 早盘股价大涨147.98%报3.08美元
Biovie Inc盘中异动 早盘大幅上涨5.08%报1.24美元
自选股智能写手 · 02-26
Biovie Inc盘中异动 早盘大幅上涨5.08%报1.24美元
Biovie Inc盘中异动 快速拉升5.45%报1.16美元
自选股智能写手 · 02-14
Biovie Inc盘中异动 快速拉升5.45%报1.16美元
加载更多
公司概况
公司名称:
BioVie Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
BioVie Inc.成立于2013年4月10日,是一家内华达州公司。该公司是一家临床阶段的公司,致力于开发创新药物疗法,以治疗慢性衰弱疾病,包括神经和神经退行性疾病以及肝脏疾病。
发行价格:
--
{"stockData":{"symbol":"BIVI","market":"US","secType":"STK","nameCN":"BioVie Inc","latestPrice":0.4542,"timestamp":1716580800000,"preClose":0.46,"halted":0,"volume":857978,"hourTrading":{"tag":"盘后","latestPrice":0.47,"preClose":0.4542,"latestTime":"19:49 EDT","volume":14310,"amount":6590.461801,"timestamp":1716594565557},"delay":0,"floatShares":37069940,"shares":60969846,"eps":-0.953947,"marketStatus":"休市中","marketStatusCode":7,"change":-0.0058,"latestTime":"05-24 16:00:00 EDT","open":0.465,"high":0.469,"low":0.4402,"amount":387270.97802,"amplitude":0.062609,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.953947,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1716883200000},"adr":0,"adjPreClose":0.46,"preHourTrading":{"tag":"盘前","latestPrice":0.465,"preClose":0.46,"latestTime":"09:22 EDT","volume":2360,"amount":1111.622139,"timestamp":1716556964943},"postHourTrading":{"tag":"盘后","latestPrice":0.47,"preClose":0.4542,"latestTime":"19:49 EDT","volume":14310,"amount":6590.461801,"timestamp":1716594565557},"volumeRatio":1.721937321099746},"requestUrl":"/m/hq/s/BIVI","defaultTab":"news","newsList":[{"id":"2429978245","title":"Biovie Inc.盘中异动 股价大跌5.04%报0.462美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429978245","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429978245?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:04","pubTimestamp":1713798252,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日23时04分,Biovie Inc.股票出现波动,股价快速跳水5.04%。截至发稿,该股报0.462美元/股,成交量20.4682万股,换手率0.37%,振幅3.66%。Biovie Inc.股票所在的生物技术行业中,整体涨幅为1.12%。Biovie Inc.公司简介:BioVie Inc 是一家临床阶段公司,开发创新药物疗法来治疗慢性衰弱性疾病,包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222304127a549b2c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404222304127a549b2c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426736530","title":"Biovie Inc.盘中异动 股价大涨5.23%报0.521美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426736530","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426736530?lang=zh_cn&edition=full","pubTime":"2024-04-12 22:34","pubTimestamp":1712932464,"startTime":"0","endTime":"0","summary":"北京时间2024年04月12日22时34分,Biovie Inc.股票出现波动,股价大幅上涨5.23%。截至发稿,该股报0.521美元/股,成交量25.5267万股,换手率0.46%,振幅9.93%。Biovie Inc.股票所在的生物技术行业中,整体跌幅为0.77%。Biovie Inc.公司简介:BioVie Inc 是一家临床阶段公司,开发创新药物疗法来治疗慢性衰弱性疾病,包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041222342479203c9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041222342479203c9f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424828844","title":"Biovie Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424828844","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424828844?lang=zh_cn&edition=full","pubTime":"2024-04-03 22:14","pubTimestamp":1712153661,"startTime":"0","endTime":"0","summary":"北京时间2024年04月03日22时14分,Biovie Inc.股票出现波动,股价大幅下跌5.06%。Biovie Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,方舟生物医药、Kintara Therapeutics, Inc.、Vanda Pharmaceuticals Inc.涨幅较大,Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.较为活跃,换手率分别为388.51%、274.34%、40.34%,振幅较大的相关个股有Kintara Therapeutics, Inc.、方舟生物医药、Vanda Pharmaceuticals Inc.,振幅分别为69.52%、53.80%、42.46%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032214217a50f9dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404032214217a50f9dd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472686","title":"Biovie Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472686","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420472686?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:49","pubTimestamp":1710769776,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时49分,Biovie Inc.股票出现异动,股价急速下挫5.00%。截至发稿,该股报0.670美元/股,成交量17.8849万股,换手率0.33%,振幅5.35%。Biovie Inc.股票所在的生物技术行业中,整体跌幅为0.06%。Biovie Inc.公司简介:BioVie Inc 是一家临床阶段公司,开发创新药物疗法来治疗慢性衰弱性疾病,包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318214936791b35b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240318214936791b35b4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419607304","title":"Biovie Inc.盘中异动 早盘快速下跌5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2419607304","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419607304?lang=zh_cn&edition=full","pubTime":"2024-03-14 21:49","pubTimestamp":1710424150,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日21时49分,Biovie Inc.股票出现异动,股价急速下跌5.42%。Biovie Inc.股票所在的生物技术行业中,整体涨幅为0.01%。Biovie Inc.公司简介:BioVie Inc 是一家临床阶段公司,开发创新药物疗法来治疗慢性衰弱性疾病,包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142149117a4cb684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142149117a4cb684&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417124224","title":"Biovie Inc.盘中异动 急速下挫5.05%报0.857美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2417124224","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417124224?lang=zh_cn&edition=full","pubTime":"2024-03-07 04:41","pubTimestamp":1709757716,"startTime":"0","endTime":"0","summary":"北京时间2024年03月07日04时41分,Biovie Inc.股票出现异动,股价大幅跳水5.05%。截至发稿,该股报0.857美元/股,成交量247.01万股,换手率6.19%,振幅7.36%。Biovie Inc.股票所在的生物技术行业中,整体涨幅为0.12%。其相关个股中,知临集团、Nkgen Biotech Inc C/Wts 31/05/2028、Biomx Inc.涨幅较大,知临集团、Nkgen Biotech, Inc.、Biomx Inc.较为活跃,换手率分别为1565.22%、478.07%、299.21%,振幅较大的相关个股有知临集团、Nkgen Biotech, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028,振幅分别为1024.76%、336.43%、255.70%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307044156861dbe39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240307044156861dbe39&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2416604649","title":"Biovie Inc.盘中异动 早盘股价大涨147.98%报3.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416604649","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416604649?lang=zh_cn&edition=full","pubTime":"2024-03-01 22:31","pubTimestamp":1709303501,"startTime":"0","endTime":"0","summary":"北京时间2024年03月01日22时31分,Biovie Inc.股票出现异动,股价急速拉升147.98%。Biovie Inc.股票所在的生物技术行业中,整体涨幅为0.86%。Biovie Inc.公司简介:BioVie Inc 是一家临床阶段公司,开发创新药物疗法来治疗慢性衰弱性疾病,包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012231418af5df40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403012231418af5df40&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414839979","title":"Biovie Inc盘中异动 早盘大幅上涨5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2414839979","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414839979?lang=zh_cn&edition=full","pubTime":"2024-02-26 23:35","pubTimestamp":1708961720,"startTime":"0","endTime":"0","summary":"北京时间2024年02月26日23时35分,Biovie Inc股票出现异动,股价快速拉升5.08%。截至发稿,该股报1.24美元/股,成交量2.6248万股,换手率0.07%,振幅5.92%。Biovie Inc股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,Zyversa Therapeutics Inc、Krystal Biotech Inc、Ocean Biomedical Inc C/Wts 14/02/2028 涨幅较大,Zyversa Therapeutics Inc、Ocean Biomedical Inc、Lixte Biotechnology Holdings Inc较为活跃,换手率分别为1384.46%、80.70%、62.29%,振幅较大的相关个股有Zyversa Therapeutics Inc、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Ocean Biomedical Inc,振幅分别为144.82%、62.88%、61.14%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262335207a46f10d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402262335207a46f10d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2411020083","title":"Biovie Inc盘中异动 快速拉升5.45%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2411020083","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411020083?lang=zh_cn&edition=full","pubTime":"2024-02-14 22:38","pubTimestamp":1707921537,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日22时38分,Biovie Inc股票出现波动,股价急速拉升5.45%。截至发稿,该股报1.16美元/股,成交量7148股,换手率0.02%,振幅3.64%。Biovie Inc股票所在的生物技术行业中,整体涨幅为0.43%。Biovie Inc公司简介:BioVie Inc 是一家临床阶段公司,开发创新药物疗法来治疗慢性衰弱性疾病,包括肝病、神经系统和神经退行性疾病以及某些癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402142238587a43a54b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402142238587a43a54b&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.bioviepharma.com","stockEarnings":[{"period":"1week","weight":-0.0765},{"period":"1month","weight":-0.1013},{"period":"3month","weight":-0.6151},{"period":"6month","weight":-0.9089},{"period":"1year","weight":-0.9288},{"period":"ytd","weight":-0.6395}],"compareEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0.0475},{"period":"3month","weight":0.0425},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.2768},{"period":"ytd","weight":0.1139}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioVie Inc.成立于2013年4月10日,是一家内华达州公司。该公司是一家临床阶段的公司,致力于开发创新药物疗法,以治疗慢性衰弱疾病,包括神经和神经退行性疾病以及肝脏疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.024941},{"month":2,"riseRate":0.5,"avgChangeRate":0.343428},{"month":3,"riseRate":0.666667,"avgChangeRate":-0.007393},{"month":4,"riseRate":0.333333,"avgChangeRate":0.031293},{"month":5,"riseRate":0.142857,"avgChangeRate":-0.161179},{"month":6,"riseRate":0.666667,"avgChangeRate":0.617874},{"month":7,"riseRate":0.666667,"avgChangeRate":0.49039},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.107609},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.163736},{"month":10,"riseRate":0.333333,"avgChangeRate":0.067701},{"month":11,"riseRate":0.5,"avgChangeRate":0.012606},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.089981}],"exchange":"NASDAQ","name":"BioVie Inc","nameEN":"BioVie Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioVie Inc,BIVI,BioVie Inc股票,BioVie Inc股票老虎,BioVie Inc股票老虎国际,BioVie Inc行情,BioVie Inc股票行情,BioVie Inc股价,BioVie Inc股市,BioVie Inc股票价格,BioVie Inc股票交易,BioVie Inc股票购买,BioVie Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioVie Inc(BIVI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioVie Inc(BIVI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}